NOVARTIS PHARMS CORP

Active trials

• —A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Koreacompletedn=140
• phase2Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patientscompletedn=215
• —A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russiacompletedn=2,390
• —A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4/6 Inhibition in HR+, HER2-negative Metastatic Breast Cancer Patientscompletedn=945
• phase2Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)completedn=163
• phase3A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.recruitingn=188
• phase4Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosisactive not recruitingn=24
• phase3A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Diseaserecruitingn=770